密度	1.23±0.1 g/cm3 (20 ºC

没有数据	没有数据

来源	SDS样本
没有数据	没有数据

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Naftopidil induces apoptosis in malignant mesothelioma cell lines independently of α1-adrenoceptor blocking.Eriko Masachika et al.Anticancer research, 33(3), 887-894 (2013-03-14) Inhibition of Cdk4 activity enhances translation of p27kip1 in quiescent Rb-negative cells.Teresa González et al.The Journal of biological chemistry, 278(15), 12688-12695 (2003-02-05) Inhibition of Cdk4 activity enhances translation of p27kip1 in quiescent Rb-negative cells.Teresa González et al.The Journal of biological chemistry, 278(15), 12688-12695 (2003-02-05) Naftopidil inhibits 5-hydroxytryptamine-induced bladder contraction in rats.Takumi Sakai et al.European journal of pharmacology, 700(1-3), 194-200 (2013-01-01) Binding characteristics of naftopidil and alpha 1-adrenoceptor antagonists to prostatic alpha-adrenoceptors in benign prostatic hypertrophy.S Yamada et al.Life sciences, 50(2), 127-135 (1992-01-01) [A randomized controlled study comparing clinical effects of naftopidil and tamsulosin on benign prostatic hyperplasia].Shugo Hanyu et al.Hinyokika kiyo. Acta urologica Japonica, 56(9), 489-494 (2010-10-14) Naftopidil, a new adrenoceptor blocking agent with Ca(2+)-antagonistic properties: interaction with adrenoceptors.G Sponer et al.Journal of cardiovascular pharmacology, 20(6), 1006-1013 (1992-12-01) Excitatory effect of propiverine hydrochloride on urethral activity in rats.Katsumi Kadekawa et al.International journal of urology : official journal of the Japanese Urological Association, 19(6), 575-582 (2012-03-02) Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients.Yasuo Tsuzaka et al.International journal of urology : official journal of the Japanese Urological Association, 18(11), 792-795 (2011-09-16) [Efficacy of naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia: prospective randomized controlled study to compare differences in efficacy between morning and evening medication].Hideki Sakai et al.Hinyokika kiyo. Acta urologica Japonica, 57(1), 7-13 (2011-02-10) Naftopidil and tolterodine in the medical expulsive therapy for intramural ureteral stones: a prospective randomized study.Jian Lin Lu et al.Urological research, 40(6), 757-762 (2012-08-29) Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.Hideyasu Tsumura et al.International journal of radiation oncology, biology, physics, 81(4), e385-e392 (2011-06-15) [Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment].Akira Suzuki et al.Hinyokika kiyo. Acta urologica Japonica, 56(4), 215-219 (2010-05-08) Facilitation of expulsion of ureteral stones by addition of α1-blockers to conservative therapy.Kenji Ohgaki et al.Scandinavian journal of urology and nephrology, 44(6), 420-424 (2010-07-08) Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.Teruhiko Yokoyama et al.International journal of urology : official journal of the Japanese Urological Association, 18(3), 225-230 (2011-01-29) Asymmetric aminolytic kinetic resolution of racemic epoxides using recyclable chiral polymeric Co(III)-salen complexes: a protocol for total utilization of racemic epoxide in the synthesis of (R)-Naftopidil and (S)-Propranolol.Manish Kumar et al.The Journal of organic chemistry, 78(18), 9076-9084 (2013-08-01) Naftopidil, a selective {alpha}1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma.Yasuhide Hori et al.Cancer prevention research (Philadelphia, Pa.), 4(1), 87-96 (2011-01-06) Analysis of energy loss mediated by an alpha-1 blocker in patients with benign prostatic hyperplasia using a virtual urethra processed from an endoscopic video image.Tomokazu Sazuka et al.Journal of endourology, 26(9), 1216-1220 (2012-04-11) Effect of naftopidil, an alpha1D/A-adrenoceptor antagonist, on the urinary bladder in rats with spinal cord injury.Katsumi Kadekawa et al.Life sciences, 92(20-21), 1024-1028 (2013-04-16) Determination of naftopidil enantiomers in rat plasma using chiral solid phases and pre-column derivatization high-performance liquid chromatography.Xiawen Liu et al.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 907, 140-145 (2012-10-03) The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews.JinQiu Yuan et al.Current medical research and opinion, 29(3), 279-287 (2013-01-18) [Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy].Noritaka Kamimura et al.Hinyokika kiyo. Acta urologica Japonica, 57(2), 71-76 (2011-03-18) [Comparison of naftopidil and silodosin in the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, crossover study].Mitsunobu Masuda et al.Hinyokika kiyo. Acta urologica Japonica, 58(12), 671-678 (2013-01-19) Antitumor action of α(1)-adrenoceptor blockers on human bladder, prostate and renal cancer cells.Akinobu Gotoh et al.Pharmacology, 90(5-6), 242-246 (2012-09-26) [Efficacy of naftopidil for nocturia and consequent sleep disturbance in patients with benign prostatic hyperplasia].Hideaki Iwaki et al.Hinyokika kiyo. Acta urologica Japonica, 56(4), 209-213 (2010-05-08) A prospective, randomized, controlled, multicenter study of naftopidil for treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia: 75 mg once daily in the evening compared to 25 mg thrice daily.Shinji Tsuritani et al.Urologia internationalis, 85(1), 80-87 (2010-06-03) Predictive factors for the effect of the α1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunction.Masayuki Takeda et al.BJU international, 108(1), 100-107 (2010-11-11) Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment.Toyohiko Watanabe et al.BJU international, 108(2), 248-251 (2010-10-05) Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones.Shui Gen Zhou et al.World journal of urology, 29(6), 767-771 (2011-08-17) Comparison of the effects of four α1-adrenoceptor antagonists on ejaculatory function in rats.Satoshi Tatemichi et al.Urology, 80(2), 486-486 (2012-06-09)

备注